根据一份提交给美国证券交易委员会的文件,生物修复疗法公司(BioRestorative Therapies, Inc.)已任命凯瑟琳·菲尔德(Katharyn Field)担任首席执行官、总裁及临时首席财务官,该任命将于2026年7月13日正式生效。
根据一份提交给美国证券交易委员会的文件,生物修复疗法公司(BioRestorative Therapies, Inc.)已任命凯瑟琳·菲尔德(Katharyn Field)担任首席执行官、总裁及临时首席财务官,该任命将于2026年7月13日正式生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.